AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28498191 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother Support Groups (MSGs)
Number of subjects: 348
Study 26156797 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 690
Study 26156797 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS (140 g/d)
Number of subjects: 690
Study 26156797 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART + LNS
Number of subjects: 690
Study 26156797 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS (without HAART)
Number of subjects: 690
Study 26156797 — intervention group
Group type: COMPARATOR
Intervention: Control (no HAART/no LNS)
Number of subjects: 690
Study 24910828 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 0
Study 24910828 — intervention group
Group type: COMPARATOR
Intervention: Control group (diabetes support and education)
Number of subjects: 0
Study 21674263 — intervention group
Group type: EXPERIMENTAL
Intervention: New formulations of ziprasidone (inclusion complex with cyclodextrin, nano-suspension, semi-ordered HCl in polymer matrix)
Number of subjects: 0
Study 21674263 — intervention group
Group type: EXPERIMENTAL
Intervention: New formulations of ziprasidone
Number of subjects: 0
Study 21674263 — intervention group
Group type: COMPARATOR
Intervention: Commercial capsules (Geodon®) dosed in the fed state
Number of subjects: 0
Study 18551084 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg 17beta-estradiol and 2 mg drospirenone (DRSP)
Number of subjects: 47
Study 17140165 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide membrane (Polyflux 14; PA group)
Number of subjects: 14
Study 17140165 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysulfone membrane (Diacap Polysulfone HI PS 15; PS group)
Number of subjects: 14
Study 14568511 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical isolation of the tongue with a latex sheet
Number of subjects: 8
Study 14568511 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-circuiting of tongue to gingival pouch
Number of subjects: 8
Study 14568511 — intervention group
Group type: COMPARATOR
Intervention: Tongue movement
Number of subjects: 8
Study 10872014 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention targeting mass media, community organizations, and education for 18 months (n=10563)
Number of subjects: 20564
Study 10872014 — intervention group
Group type: COMPARATOR
Intervention: Reference status (n=9801)
Number of subjects: 20564
Study 10872014 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention (n=10563)
Number of subjects: 20564
Study 19479398 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with paclitaxel (200 mg/m²) and carboplatin (AUC 6) for 3 cycles (q21)
Number of subjects: 23
Study 19479398 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with paclitaxel and carboplatin
Number of subjects: 23
Study 8245523 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 micrograms of rgp160-mam vaccine
Number of subjects: 60
Study 8245523 — intervention group
Group type: EXPERIMENTAL
Intervention: 50.0 micrograms of rgp160-mam vaccine
Number of subjects: 60
Study 8245523 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms of rgp160-mam vaccine (boosted at 18 months)
Number of subjects: 60
Study 8245523 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant control
Number of subjects: 60
Study 2875676 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam
Number of subjects: 0
Study 2875676 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study 30142768 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and IVF‐ET combined treatment group
Number of subjects: 70
Study 30142768 — intervention group
Group type: COMPARATOR
Intervention: IVF‐ET single treatment group
Number of subjects: 70
Study 27566781 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled evening sleep and enhanced lighting during night shifts
Number of subjects: 18
Study 27566781 — intervention group
Group type: COMPARATOR
Intervention: Ad-lib sleep and typical lighting during night shifts
Number of subjects: 18
Study 23764717 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope (GS)
Number of subjects: 60
Study 23764717 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 60
Study 23057533 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection lipolysis and hyaluronic acid dermal filler
Number of subjects: 24
Study 23057533 — intervention group
Group type: COMPARATOR
Intervention: Injection lipolysis and hyaluronic acid dermal filler + non-ablative 1540 fractional laser
Number of subjects: 24
Study 21411505 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng root extract (8 g/day)
Number of subjects: 0
Study 21411505 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginsenoside Re (250‐500 mg/day)
Number of subjects: 0
Study 21411505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19145924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment
Number of subjects: 0
Study 19145924 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 16837126 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10mg once a day
Number of subjects: 14
Study 16837126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12813332 — intervention group
Group type: EXPERIMENTAL
Intervention: UFH-IPC (unfractionated heparin plus intermittent pneumatic compression)
Number of subjects: 107
Study 12813332 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 107
Study 12813332 — intervention group
Group type: EXPERIMENTAL
Intervention: UFH-IPC
Number of subjects: 107
Study 10906624 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (aggressive lipid-lowering therapy)
Number of subjects: 0
Study 10906624 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 0
Study 10906624 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril (ACE inhibitor)
Number of subjects: 0
Study 10906624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9026318 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 79
Study 9026318 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin E supplementation)
Number of subjects: 79
Study 1731548 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid administration of midazolam (0.1 mg/kg IV over 15 s)
Number of subjects: 10
Study 1731548 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow administration of midazolam (0.1 mg/kg IV over 5 min)
Number of subjects: 10
Study 6608846 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (1500 mg/24 hours IV + 200 mg orally every 8th hour for 3 days, then 200 mg orally 3 times daily)
Number of subjects: 40
Study 6608846 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (10 mg every 6th hour)
Number of subjects: 40
Study 31251550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clascoterone 1% BID
Number of subjects: 363
Study 31251550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clascoterone 0.1% BID
Number of subjects: 363
Study 31251550 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 363
Study 31251550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clascoterone 0.5% BID
Number of subjects: 363
Study 31251550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clascoterone 1% QD
Number of subjects: 363
Study 29126918 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI) promoting physical activity based on Japanese guidelines; conducted from 2013 to 2015, involving information dissemination, education, and community support.
Number of subjects: 3000
Study 29126918 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI) promoting physical activity based on Japanese guidelines.
Number of subjects: 3000
Study 26471807 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Proseal (PLMA)
Number of subjects: 90
Study 26471807 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel airway (IGA)
Number of subjects: 90
Study 26471807 — intervention group
Group type: COMPARATOR
Intervention: Both PLMA and IGA
Number of subjects: 90
Study 24595801 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 plus cisplatin and paclitaxel (2 courses)
Number of subjects: 75
Study 24595801 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 plus cisplatin and paclitaxel (4 courses)
Number of subjects: 75
Study 24595801 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study 22020236 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation
Number of subjects: 40
Study 20335484 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized beta-band activity of a neuronal group
Number of subjects: 0
Study 17343554 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at a dosage of 0.25 mg/kg
Number of subjects: 24
Study 16623024 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera cream applied 30 minutes before, immediately after, or both before and after UV exposure
Number of subjects: 20
Study 16623024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12135309 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 46
Study 12135309 — intervention group
Group type: EXPERIMENTAL
Intervention: Temocapril
Number of subjects: 46
Study 12135309 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 46
Study 10458346 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical potassium
Number of subjects: 39
Study 10458346 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 39
Study 8665878 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warming with a radiant heater (500 W)
Number of subjects: 30
Study 8665878 — intervention group
Group type: COMPARATOR
Intervention: Passive rewarming with a reflective blanket
Number of subjects: 30
Study 2079425 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene diphosphonate kits (various brands)
Number of subjects: 134
Study 7426527 — intervention group
Group type: EXPERIMENTAL
Intervention: Omnopon by intramuscular injection for 24 hours after operation
Number of subjects: 0
Study 7426527 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol by intravenous infusion
Number of subjects: 0
Study 7426527 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Omnopon and Salbutamol)
Number of subjects: 0
Study 31271045 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy with adjustment of the challenge-skill balance
Number of subjects: 72
Study 31271045 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy
Number of subjects: 72
Study 31271045 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 26912728 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners in Dementia Care (PDC) intervention
Number of subjects: 316
Study 26233871 — intervention group
Group type: EXPERIMENTAL
Intervention: Onion peel extract (OPE) 100mg quercetin/d, 50mg quercetin twice daily; n=36 participants
Number of subjects: 72
Study 26233871 — intervention group
Group type: EXPERIMENTAL
Intervention: Onion peel extract (OPE)
Number of subjects: 72
Study 26233871 — intervention group
Group type: COMPARATOR
Intervention: Placebo; n=36 participants
Number of subjects: 72
Study 23585168 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Appendectomy (LA)
Number of subjects: 86
Study 23585168 — intervention group
Group type: COMPARATOR
Intervention: Conventional Appendectomy (OA)
Number of subjects: 86
Study 21123320 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid factor (RF) positivity
Number of subjects: 0
Study 21123320 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking at baseline
Number of subjects: 0
Study 19143950 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mcg.kg(‐1) IV fentanyl
Number of subjects: 100
Study 19143950 — intervention group
Group type: COMPARATOR
Intervention: 2% lignocaine gel applied over the cornea of the operative eye
Number of subjects: 100
Study 18342502 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive acute lymphoblastic leukaemia type chemotherapy regimen without irradiation
Number of subjects: 121
Study 15386806 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone plus insulin (insulin + RSG group)
Number of subjects: 23
Study 15386806 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin alone (insulin group)
Number of subjects: 23
Study 12010890 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg twice daily
Number of subjects: 83
Study 12010890 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg twice daily
Number of subjects: 83
Study 12010890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 10588589 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory pressure support (PS = 4.8 +/- 0.2 cm H(2)O)
Number of subjects: 12
Study 7872216 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusively breast-feeding for the first 6 months
Number of subjects: 141
Study 7872216 — intervention group
Group type: COMPARATOR
Intervention: Complementing breast milk with prepared solid foods beginning at 4 months
Number of subjects: 141
Study 2239755 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 0
Study 2239755 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish diet (predominantly vegetarian with fish consumed at least three times per week)
Number of subjects: 0
Study 2239755 — intervention group
Group type: COMPARATOR
Intervention: Usual meat-eating diet
Number of subjects: 0
Study 414266 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine - 25 mg t.d.s.
Number of subjects: 40
Study 414266 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine - 50 mg t.d.s.
Number of subjects: 40
Study 414266 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 414266 — intervention group
Group type: COMPARATOR
Intervention: Control - no tablets
Number of subjects: 40
Study 31742891 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modifications including reducing body weight and salt intake
Number of subjects: 0
Study 31742891 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BP treatment targets (not specifically defined)
Number of subjects: 0
Study 31558733 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 86
Study 31558733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 29291366 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women with intrauterine infection (n=93)
Number of subjects: 250
Study 29291366 — intervention group
Group type: COMPARATOR
Intervention: Comparison group of pregnant carriers of perinatally significant infection (n=157)
Number of subjects: 250
Study 29291366 — intervention group
Group type: COMPARATOR
Intervention: Control group of healthy women (n=50)
Number of subjects: 250
Study 26096799 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicardial CRT
Number of subjects: 7
Study 26096799 — intervention group
Group type: COMPARATOR
Intervention: Endocardial CRT
Number of subjects: 7
Study 26096799 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 7
Study 23153515 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted ergonomic intervention program (8-week duration including ergonomic training, daily exercise program, equipment modification, computer workstation assessment, typing training)
Number of subjects: 50
Study 23153515 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted ergonomic intervention program
Number of subjects: 50
Study 21663513 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan and prednisone plus thalidomide (MPT)
Number of subjects: 135
Study 21663513 — intervention group
Group type: COMPARATOR
Intervention: Melphalan and prednisone (MP)
Number of subjects: 135
Study 17644552 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 0
Study 17644552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16556618 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplements (beta carotene and vitamins C and E)
Number of subjects: 798
Study 16556618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 798
Study 12926746 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and application of tap water flavoured with eucalyptus oil
Number of subjects: 15
Study 12926746 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and application of Cervitec (1% chlorhexidine in thymol-containing varnish)
Number of subjects: 15
Study 12926746 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and application of Cervitec and Fluor Protector (varnish containing 0.1% fluoride)
Number of subjects: 15
Study 12926746 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups combined
Number of subjects: 15
Study 11007223 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (200 mg intravenously over 20 min, followed by 100 mg over the next 40 min)
Number of subjects: 8
Study 11007223 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 8
Study 8788536 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg, equivalent to 2-3 cups of coffee)
Number of subjects: 48
Study 8788536 — intervention group
Group type: COMPARATOR
Intervention: Control (no caffeine)
Number of subjects: 48
Study 1632541 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low-dose infusion of 0.125% bupivacaine at 6 mL/h after a 3-in-1 nerve block with 30 mL of 0.25% bupivacaine
Number of subjects: 37
Study 1632541 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional intramuscularly administered narcotics)
Number of subjects: 37
Study 6437476 — intervention group
Group type: EXPERIMENTAL
Intervention: Two stage ultrasound screening schedule
Number of subjects: 877
Study 6437476 — intervention group
Group type: COMPARATOR
Intervention: Routine application of two stage ultrasound screening
Number of subjects: 877
Study 31585008 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower resting-state complexity within sensorimotor, executive and attention networks
Number of subjects: 53
Study 31585008 — intervention group
Group type: EXPERIMENTAL
Intervention: Complexity in sensorimotor, executive and attention networks
Number of subjects: 53
Study 28088776 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR
Number of subjects: 5552
Study 28088776 — intervention group
Group type: EXPERIMENTAL
Intervention: eAER
Number of subjects: 5552
Study 27536093 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual educational interventions (three groups)
Number of subjects: 91
Study 27536093 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet (control group)
Number of subjects: 91
Study 24872540 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening with major abnormality not suspicious for lung cancer
Number of subjects: 15489
Study 24872540 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening with suspicious for lung cancer but stable from previous screens
Number of subjects: 15489
Study 24872540 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening with suspicious for lung cancer and new or changed from previous screen
Number of subjects: 15489
Study 24872540 — intervention group
Group type: COMPARATOR
Intervention: Normal lung cancer screening results
Number of subjects: 15489
Study 22974129 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (IT)
Number of subjects: 60
Study 22974129 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (MT)
Number of subjects: 60
Study 22974129 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) only
Number of subjects: 60
Study 22974129 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (IT, MT, OMT)
Number of subjects: 60
Study 25427182 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing with adjunctive laser therapy (5W), n=28
Number of subjects: 8
Study 25427182 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (control), n=28
Number of subjects: 8
Study 25427182 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser surgery (7W) for remaining pockets
Number of subjects: 8
Study 25427182 — intervention group
Group type: COMPARATOR
Intervention: Gingivectomy (control) for remaining pockets
Number of subjects: 8
Study 18534500 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior cruciate-retaining (CR) total knee arthroplasties (TKAs)
Number of subjects: 60
Study 18534500 — intervention group
Group type: COMPARATOR
Intervention: Posterior cruciate-substituting (PS) total knee arthroplasties (TKAs)
Number of subjects: 60
Study 16036208 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (0.7 g/kg for males and 0.6 g/kg for females)
Number of subjects: 32
Study 11829698 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatment
Number of subjects: 120
Study 11829698 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/d)
Number of subjects: 120
Study 10640168 — intervention group
Group type: EXPERIMENTAL
Intervention: MPA/E2C
Number of subjects: 1103
Study 10640168 — intervention group
Group type: COMPARATOR
Intervention: NET/EE (new users)
Number of subjects: 1103
Study 10640168 — intervention group
Group type: COMPARATOR
Intervention: NET/EE (previous users)
Number of subjects: 1103
Study 7791577 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (E) exercised for 30 min, 3 d.wk‐1 for 12 wk at 70% (initial 6 wk) and 80% (latter 6 wk) of maximum heart rate.
Number of subjects: 25
Study 7791577 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) maintained normal activity pattern.
Number of subjects: 25
Study 7791577 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (E) post conditioning RFC.
Number of subjects: 25
Study 7791577 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups pre and post conditioning after maximal exercise.
Number of subjects: 25